OrbiMed Capital GP VII LLC

Director, 10% OwnerKinnate Biopharma Inc. (KNTE) · full profile →Form 4 · filed May 2, 2023
Net Buying
Open-Market Buys
$3.7M
Open-Market Sells
$0
Net Open-Market Flow
$3.7M
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2023Buy(P)59K$2.67$157K794K
May 2, 2023Buy(P)59K$2.67$157K794K
May 2, 2023Buy(P)221K$2.67$589K4.4M
May 1, 2023Buy(P)125K$2.62$326K736K
May 1, 2023Buy(P)125K$2.62$326K736K
May 1, 2023Buy(P)467K$2.62$1.2M4.2M
Apr 28, 2023Buy(P)229K$2.55$583K3.7M
Apr 28, 2023Buy(P)61K$2.55$156K611K
Apr 28, 2023Buy(P)61K$2.55$156K611K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-23-000515) within minutes of acceptance. Every field above traces to the original document. Verify it directly: